NASDAQ: CURX
Curanex Pharmaceuticals Inc Stock Ownership - Who owns Curanex Pharmaceuticals?

Insider buying vs selling

Have Curanex Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CURX insiders and whales buy or sell their stock.

CURX Shareholders

What type of owners hold Curanex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Chang Liu69.01%1,082,200$5.45MInsider
Dian Ying Jing44.00%690,000$3.48MInsider
Jun Liu44.00%690,000$3.48MInsider
Citade0.01%95$478.80Institution
Citadel Advisors LLC0.01%95$478.80Institution
Renaissance Technologies LLC0.00%52$262.08Institution
Rentec0.00%52$262.08Institution
Virtu Financial LLC0.00%51$257.04Institution
Virtuf0.00%51$257.04Institution
Geodec0.00%38$191.52Institution

1 of 3

CURX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CURX0.01%99.99%
ERNA0.00%100.00%Net Buying
ENVB0.01%15.55%
CELZ0.01%0.53%
CDIO0.00%100.00%

Curanex Pharmaceuticals Stock Ownership FAQ

Who owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals (NASDAQ: CURX) is owned by 0.02% institutional shareholders, 157.00% Curanex Pharmaceuticals insiders, and 0.00% retail investors. Chang Liu is the largest individual Curanex Pharmaceuticals shareholder, owning 1.08M shares representing 69.01% of the company. Chang Liu's Curanex Pharmaceuticals shares are currently valued at $4.55M.

If you're new to stock investing, here's how to buy Curanex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.